MADRID--(BUSINESS WIRE)--“This is a key milestone in validating a definitive Atrial Fibrillation (AF) ablation system using PFA and Optical Coherence Reflectometry (OCR) to monitor and confirm the ...
MIAMI--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablationâ„¢ (nanosecond PFA or nsPFAâ„¢) technology, today announced ...
Nanosecond PFA Percutaneous Electrode System to be highlighted in clinical science and video sessions MIAMI--(BUSINESS WIRE)-- Pulse Biosciences, Inc. (PLSE), a company leveraging its novel and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results